Trial Status
Open for enrollment

What is the Purpose of this Study?
To better understand what the cause of IBM is, by collecting clinical information and performing genetic studies on a blood sample.

Who is Eligible to Participate?
Patients over the age of 30 with a diagnosis of IBM, Dermatomyositis, Polymyositis or Tubular Aggregate Myopathy and willing to donate blood. Patients will also have to meet all inclusion criteria which will be explained in greater detail by the study coordinator.

What is involved in this Study?
Participant samples of blood will be collected from patients with the diagnosis of IBM, Dermatomyositis, Polymyositis or Tubular Aggregate Myopathy.

How long is the Study?
This study includes only one clinical visit.

For more information contact:
Lynette McKinney, MSCS, CRC, Study Coordinator at 602-358-2271 or lmckinney@pnal.net